Regenxbio
(NASDAQ) RGNX
Regenxbio Financials at a Glance
Market Cap
$426.32M
Revenue (TTM)
$170.44M
Net Income (TTM)
$193.88M
EPS (TTM)
$-3.75
P/E Ratio
-2.20
Dividend
$0.00
Beta (Volatility)
1.49 (Average)
Dividend
$0.00
Beta (Volatility)
1.49 (Average)
Price
$7.78
Volume
26,083
Open
$8.20
Price
$7.78
Volume
26,083
Open
$8.20
Previous Close
$7.78
Daily Range
$7.71 - $8.26
52-Week Range
$5.04 - $16.19
Dividend
$0.00
Beta (Volatility)
1.49 (Average)
Price
$7.78
Volume
26,083
Open
$8.20
Previous Close
$7.78
Daily Range
$7.71 - $8.26
52-Week Range
$5.04 - $16.19
RGNX News
Why Regenxbio Stock Is Way Up Today
RGNX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Regenxbio
Industry
Biotechnology
Sector
Health CareEmployees
371
CEO
Curran M. Simpson
Website
www.regenxbio.comHeadquarters
Rockville, MD 20850, US
RGNX Financials
Key Financial Metrics (TTM)
Gross Margin
53%
Operating Margin
-95%
Net Income Margin
-1%
Return on Equity
-107%
Return on Capital
-48%
Return on Assets
-43%
Earnings Yield
-45.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$426.32M
Shares Outstanding
51.61M
Volume
26.08K
Short Interest
0.00%
Avg. Volume
1.01M
Financials (TTM)
Gross Profit
$150.14M
Operating Income
$161.20M
EBITDA
$145.58M
Operating Cash Flow
$123.96M
Capital Expenditure
$2.41M
Free Cash Flow
$126.38M
Cash & ST Invst.
$230.07M
Total Debt
$260.52M
Regenxbio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$30.34M
+43.0%
Gross Profit
$24.41M
+63.9%
Gross Margin
80.46%
N/A
Market Cap
$426.32M
N/A
Market Cap/Employee
$1.21M
N/A
Employees
353
N/A
Net Income
$67.15M
-31.2%
EBITDA
$63.33M
-67.8%
Quarterly Fundamentals
Net Cash
$30.45M
-119.9%
Accounts Receivable
$26.38M
+22.3%
Inventory
$0.00
N/A
Long Term Debt
$212.62M
+186.8%
Short Term Debt
$47.90M
+506.1%
Return on Assets
-42.80%
N/A
Return on Invested Capital
-48.13%
N/A
Free Cash Flow
$52.80M
-61.4%
Operating Cash Flow
$52.29M
-65.3%